Real Estate
Alexandria Real Estate Equities reported a Q2 FY2026 FFO of $1.73 per share, with net loss narrowing to $0.43 per share, as record leasing volume and capital recycling efforts partially mitigated headwinds from oversupply and rising vacancy.
Key risk: Life Science Real Estate Oversupply
A surge in speculative laboratory developments since the pandemic has created significant oversupply, with life science real estate availability in top markets reaching 29% in 2025, up from 4% in 2021. This oversupply continues to pressure rental rates, occupancy, and tenant improvement costs.
Other Office REITs companies